Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.
Take a Trip
Down Memory Lane.
After decades of fundamental research, there was a cultural struggle over psychedelics in the United States. Just as psychiatrists, psychologists, and other researchers were making incredible headway on their studies of compounds like LSD and psilocybin (among others), the U.S. government criminalized these substances, blocking research across the globe.
Enter our founder, Rick Doblin, Ph.D.. Knowing the DEA would move onto criminalizing MDMA, Rick (along with Alise Agar and Debby Harlow) started a nonprofit in 1984, the Earth Metabolic Design Lab. They filed a lawsuit to prevent the DEA’s effort to classify MDMA as a Schedule I substance. Unfortunately, the DEA rejected the recommendation of the judge to keep the therapeutic use of MDMA legal. But hope was not lost.
By creating MAPS in 1986, Rick was able to continue researching the healing potential of MDMA and other psychedelics. Over the course of the past 35 years, MAPS has raised over $130 million for psychedelic research and education.
Who we are
Researchers of Psychedelics, Leaders of Change.
Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit organization specializing in research and education. Our work develops medical, legal, and cultural shifts so people can benefit from the careful use of psychedelics and marijuana for mental health, well-being, and connection.
In other words, we’ve dedicated the last 36 years to changing the way people think of, talk about, and consume psychedelics through research, education, and advocacy.